Table 2.
Analysis of risk factors for CSAKI in entire cohort.
Variables | Unadjusted | Adjusted | ||||
---|---|---|---|---|---|---|
|
|
|||||
OR | 95% CI | P | OR | 95% CI | P | |
Male | 1.596 | 1.375–1.852 | < 0.001 | 2.127 | 1.759–2.571 | < 0.001 |
Age [years] | 1.030 | 1.024–1.037 | < 0.001 | 1.033 | 1.024–1.042 | < 0.001 |
Hypertension | 1.288 | 1.108–1.497 | < 0.001 | |||
NYHA classification 3–4 | 1.407 | 1.215–1.629 | < 0.001 | 1.214 | 1.002–1.471 | 0.048 |
Elevated RDW (%) | 1.335 | 1.232–1.447 | < 0.001 | 1.108 | 1.005–1.222 | 0.039 |
eGFR < 60 mL/min/1.73 m2 | 2.399 | 1.851–3.108 | < 0.001 | 1.602 | 1.124–2.284 | 0.009 |
Valve + CABG | 2.752 | 2.001–3.784 | < 0.001 | |||
CPB time > 120 min | 2.134 | 1.752–2.599 | < 0.001 | 1.919 | 1.553–2.372 | < 0.001 |
Erythrocyte transfusion [U]* | 1.340 | 1.243–1.445 | < 0.001 | 1.167 | 1.056–1.289 | 0.002 |
The amount of erythrocyte transfusion refers to the total amount of erythrocyte transfusion for each patient received on the day of surgery.
CABG —coronary artery bypass grafting; CI — confidence interval; CSAKI — cardiac surgery associated acute kidney injury; CPB — cardiopulmonary bypass; eGFR — estimated glomerular filtration rate, calculated by CKD-EPI formulae; NYHA — New York Heart Association; OR — odds ratio; RDW — red cell distribution width